InvestorsHub Logo
Followers 9
Posts 776
Boards Moderated 0
Alias Born 07/15/2017

Re: HDGabor post# 323128

Tuesday, 02/02/2021 9:22:13 PM

Tuesday, February 02, 2021 9:22:13 PM

Post# of 429650
HD no argument here I am a HS teacher and we’ve got some real literacy problems and then laziness. You pulled a couple of gems out of there

One item that struck me was the sad page 15. Look at the bar graph and the size of the bars ... Vascepa captures a very small portion of what they’re calling at-risk patients from unproven products. What is Amarin doing to address it?

I wonder how they will do this especially in the US without adding marketing or sales force.

Also the Covid spice on page 20 is the stuff that makes people dream of a runaway stock price but we know the long dreary road of waiting for data to arrive when trials complete. Cheers to upcoming interims.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News